Literature DB >> 28717923

MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.

Hao Fu1, Wenke Song2, Xuancai Chen1, Tao Guo1, Bin Duan1, Xinxi Wang1, Yachun Tang1, Liang Huang3, Chi Zhang4.   

Abstract

Accumulating evidence indicates that microRNAs are implicated in tumor initiation and progression through negatively regulating oncogenes or tumor suppressor genes. In the present study, we report that the expression of miR-200a was significantly lower in renal cell carcinoma (RCC) specimens and RCC cell lines. Restoration of miR-200a suppressed cell growth, arrested cell cycle progression, and promoted cell apoptosis in RCC cell lines. We next used qRT-PCR array technology to identify Sirtuin 1 (SIRT1) as one of the downregulated proteins during miR-200a overexpression in 786-O cells. Following a further assay by luciferase reporter system, SIRT1 was validated as a direct target of miR-200a. Moreover, siRNA-mediated knockdown of SIRT1 could partially phenocopy the effects of miR-200a overexpression. In contrast, overexpression of truncated SIRT1 (without an endogenous 3'-UTR) could rescue the effect of miR-200a overexpression on 786-O cells, which suggested that SIRT1 3'-UTR is targeted by miR-200a specifically. These observations provide further evidence for a critical tumor-suppressive role of the miR-200a in RCC in addition to identifying a novel regulatory mechanism, which may contribute to SIRT1 upregulation in RCC.

Entities:  

Keywords:  Apoptosis; MiR-200a; Renal cell carcinoma; SIRT1

Mesh:

Substances:

Year:  2017        PMID: 28717923     DOI: 10.1007/s11010-017-3102-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer.

Authors:  Niall Barron; Joanne Keenan; Patrick Gammell; Vanesa G Martinez; Alex Freeman; John R Masters; Martin Clynes
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

2.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.

Authors:  Hongping Xia; Samuel S Ng; Songshan Jiang; William K C Cheung; Johnny Sze; Xiu-Wu Bian; Hsiang-Fu Kung; Marie C Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-11-24       Impact factor: 3.575

3.  miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.

Authors:  Jiye Feng; Jinbo Wang; Mingliang Chen; Gun Chen; Zongyang Wu; Liping Ying; Qifeng Zhuo; Jianlei Zhang; Weilin Wang
Journal:  Oncol Rep       Date:  2014-12-02       Impact factor: 3.906

4.  SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.

Authors:  D Herranz; A Maraver; M Cañamero; G Gómez-López; L Inglada-Pérez; M Robledo; E Castelblanco; X Matias-Guiu; M Serrano
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

5.  Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Authors:  Hiedo Hidaka; Naohiko Seki; Hirofumi Yoshino; Takeshi Yamasaki; Yasutoshi Yamada; Nijiro Nohata; Miki Fuse; Masayuki Nakagawa; Hideki Enokida
Journal:  Oncotarget       Date:  2012-01

6.  Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.

Authors:  Lyndsay V Rhodes; Elizabeth C Martin; H Chris Segar; David F B Miller; Aaron Buechlein; Douglas B Rusch; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncotarget       Date:  2015-06-30

7.  MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.

Authors:  M Pichler; A L Ress; E Winter; V Stiegelbauer; M Karbiener; D Schwarzenbacher; M Scheideler; C Ivan; S W Jahn; T Kiesslich; A Gerger; T Bauernhofer; G A Calin; G Hoefler
Journal:  Br J Cancer       Date:  2014-02-06       Impact factor: 7.640

8.  SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells.

Authors:  Ling Li; Tereza Osdal; Yinwei Ho; Sookhee Chun; Tinisha McDonald; Puneet Agarwal; Allen Lin; Su Chu; Jing Qi; Liang Li; Yao-Te Hsieh; Cedric Dos Santos; Hongfeng Yuan; Trung-Quang Ha; Mihaela Popa; Randi Hovland; Øystein Bruserud; Bjørn Tore Gjertsen; Ya-Huei Kuo; Wenyong Chen; Sonia Lain; Emmet McCormack; Ravi Bhatia
Journal:  Cell Stem Cell       Date:  2014-10-02       Impact factor: 24.633

Review 9.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30

10.  Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

Authors:  S S Roy; V K Gonugunta; A Bandyopadhyay; M K Rao; G J Goodall; L-Z Sun; R R Tekmal; R K Vadlamudi
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

View more
  6 in total

1.  LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP.

Authors:  Zixuan Gong; Xiaoyu Chen; YueChao Zhang; Cheng Liu; Zhibing Wang; Xiaoyan Xu; Jun Zhu; Tongqing Xue
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

Review 2.  Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

3.  MicroRNA-141-3p and microRNA-200a-3p regulate α-melanocyte stimulating hormone-stimulated melanogenesis by directly targeting microphthalmia-associated transcription factor.

Authors:  Tomohiro Itoh; Kanako Fukatani; Ayaka Nakashima; Kengo Suzuki
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

4.  Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.

Authors:  Xin Wang; Youlu Lu; Zhouting Tuo; Huan Zhou; Ying Zhang; Zhangjun Cao; Longfei Peng; Dexin Yu; Liangkuan Bi
Journal:  Oncol Rep       Date:  2021-04-28       Impact factor: 3.906

Review 5.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

6.  Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma.

Authors:  Ying Tan; Bijuan Li; Fang Peng; Guanghui Gong; Ning Li
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.